Message from the CEO

I am delighted to reveal that tomorrow, MTPConnect is opening Expressions of Interest for funding under the Targeted Translation Research Accelerator (TTRA) Drugs and Devices program.

It is open to Australian spin-outs, start-ups and small to medium enterprises keen to commercialise innovative medical products to reduce the burden of cardiovascular disease and the complications of diabetes (type 1 and type 2).

EOIs need to be submitted by 4 November 2024 and companies can apply for up to $1.5 million. Detailed Funding Guidelines with further information about eligibility and the application process are already available for review on the MTPConnect website.

We know that access to funding remains the biggest challenge for startups and innovators at the early stage of innovation so this new accelerator opportunity - and prospect of much needed investment - will make a real difference.

This time next week we’ll be preparing to take a 20-strong delegation on MTPConnect’s North America medtech mission, visiting the ‘Medical Alley’ global medtech hub of Minneapolis-St Paul, Minnesota and the MedTech Conference (15 - 17 October 2024) in Toronto, Canada. With standout companies joining us and a cracking visit and networking program, along with a prominent Team Australia pavilion at the Medtech Conference, the mission is all about opening-up new market, commercial, investment and collaboration opportunities in North America.

For any life science companies keen to access US investment and collaboration, can I suggest a listen to this month’s MTPConnect Podcast episode featuring Biocom California’s Joe Panetta who provides an invitation to their Investor Conference in La Jolla, California in early 2025 as well as some insightful tips for doing business in the US.

In other international activities, MTPConnect’s Andrew Bowskill, co-chair of AAMRNet, has just returned from New York City where he was involved in a myriad of activities and side meetings around the United Nations General Assembly High-Level Meeting on Antimicrobial Resistance, one of the most significant weeks in AMR policy for many years. The meeting delivered a potent political declaration, committing to new targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial AMR annually by 10 per cent by 2030.

Through our MoU with the Korea Health Industry Development Institute (KHIDI), we are welcoming a Korean biotech delegation to Melbourne and Sydney at the end of October, organising site tours in conjunction with Austrade and hosting a special networking lunch jointly with BioNSW in Sydney on 29 October 2024 and another special networking event in Melbourne on 30 October 2024. Please register to join us in Sydney and stay tuned for details on the Melbourne event.

Back home and we announced we are partnering with AusBiotech to deliver Australia’s first National Biotech and Medtech Development and Commercialisation Summit, to be held in Canberra on 19 November 2024.

Our sector is facing challenges on many fronts - supply chains for medicines are vulnerable, sovereign capabilities remain limited and access to capital and people with the right skills is needed to grow our companies. The summit is the first time ever our industry has come together to tackle these issues with a crystalized voice to government about how Australia can supercharge the “D” in its medical R&D strategies and I couldn’t be more pleased to see MTPConnect and AusBiotech coming together to make it happen.

And coming up next month, look out for some great events we are involved with including the SABRE Futures Summit 2024 in Adelaide on 16 October 2024 which invites experts across multi-sectors to shape the future of national security through biotechnology; the Tenmile Healthtech Muster Networking event in Sydney on 17 October; and our next WA MTP Sector Spotlight featuring Agili8’s Esther Oh in Perth on 15 October.

We are also holding an invitation-only Clinical Translation and Commercialisation Medtech Symposium in Sydney on 21-22 October where we will welcome innovators in this medtech cohort for two days of commercialisation skill building through a series of workshops with sector experts.

And a reminder about another program we are involved in delivering, the Australian Clinical Entrepreneur Program, which is supporting the development and growth of clinician-led companies. Applications for nurses, doctors and allied health professionals to participate in the program in NSW and Victoria are open until Friday this week, 4 October.

In staff news, we are excited to welcome three new team members to our Adelaide team to work with Dana Bell and Jess Maxwell - Dr Nathalie Taquet joins as Business Development Director SA, Dr Santhni Subramaniam as Industry Development Officer and Belinda Turner joins as Engagement and Communications Manager.

With so much happening in the sector over the next few months, we hope you continue to enjoy our newsletter and stay connected to opportunities, events and news.

Kind regards,

Stuart Dignam
Chief Executive Officer

Drugs & Devices EOI opening 1 October 2024

MTPConnect & Industry News

MTPConnect Backs Start-ups In Heart Disease and Diabetes through New $28.5M TTRA Investment
MTPConnect is injecting much-needed funding and support for Australian small-to-medium enterprises (SMEs) to commercialise innovative medical products to better treat cardiovascular disease and diabetes with a new investment through its Targeted Translation Research Accelerator (TTRA) Drugs and Devices. An initiative of the Medical Research Future Fund, this program will accelerate promising drugs and devices focused on cardiovascular disease and the complications of diabetes (type 1 and type 2). Industry giants CSL and Roche Diagnostics have been brought into the program to ensure our home-grown innovators can tap into the very best of industry expertise and support. Applications open 1 October 2024 and close 4 November 2024. Join the information session on 8 October 2024 to find out more about eligibility and the application process. Visit the website to download the funding guidelines and sample application forms.

Announcing Medtech Delegation to North America!
We are excited to reveal the organisations joining our Medtech delegation to North America- taking in the global medtech hub of Minneapolis, Minnesota (10-11 Oct) and The MedTech Conference (15-17 Oct) in Toronto, Canada. Let’s hear it for: Design + Industry, Examin Holdings, Global Victoria, IDE Group, InnovateMedtech, Invest and Trade Western Australia, iyarn, Materia Health, Mobius Medical, NSW Health (NSW Medical Research), Optiscan Imaging Ltd, PeriCoach, Roam Technologies (roamtech.ai), SDIP Innovations Pty. Ltd., Trade and Investment Queensland, University of Melbourne (Faculty of Medicine, Dentistry and Health Sciences), Venstra Medical and WA Life Sciences Innovation Hub. Find out more about these medtech movers here!

AusBiotech and MTPConnect partner to deliver Australian first National Summit
AusBiotech and MTPConnect have announced a new partnership to deliver Australia’s first National Biotech and Medtech Development and Commercialisation Summit, to be held in Canberra on 19 November 2024. The one-day Summit is set to help future-proof the country’s access to biotech and medtech innovation.

Meet the Korean Delegation to Ausbiotech 2024
Join us in welcoming the Korean Delegation to Ausbiotech 2024 with networking events in Sydney and Melbourne. The first event, hosted BioNSW and MTPConnect in conjunction with AusTrade, kicks off in Sydney on 29 October. It will be an opportunity for the New South Wales life sciences sector to meet the Korean delegation. Tickets are strictly limited. Register here for the Sydney event. And stay tuned for details on the upcoming Melbourne event on 30 October 2024.

Why more needs to be done to support home-grown innovations
In an opinion piece for Hospital + Healthcare, our CEO Stuart Dignam shares his thoughts on the upside of backing Australian born medical innovations.

Podcast Episodes This Month!
We kicked off September with a podcast episode featuring Biocom California's Joe Panetta who shared his top tips for Australian companies looking to move into the US market and Biocom California’s upcoming Global Life Science Partnering and Investor Conference on 24-25 February 2025 which will provide an important avenue for companies to connect with investors. The most recent podcast episode focuses on precision oncology and Omico's Professor David Thomas who is behind an initiative to provide free genomic profiling for 23,000 Australians with advanced cancers, to match tumours with targeted treatments.

Taking Australia’s Fight Against Antimicrobial Resistance to the Global Stage
Our Co-chair of the Australian Antimicrobial Resistance Network and MTPConnect Director Stakeholder Engagement Queensland, Andrew Bowskill, recently represented Australia at the World AMR Congress in Philadelphia, then at the United Nations General Assembly (UNGA) in New York City featuring the eagerly anticipated High-Level Meeting on AMR. Check out Andrew's blog posts from Philadelphia and New York

Celebrate the Healthtech Innovation Networking Event of the Year!
MTPConnect is proud to be a community supporter of The Healthtech Muster networking event, brought to you by Tenmile with support from What the Health & Prime. Whether you're a health or life science expert, operator, investor, founder, researcher, student, or just curious about the space—this event is for you. To be held on Thursday 17 October from 6 pm at the Australian Maritime Museum, Sydney. Spaces are limited.

APPLAUSE24 - Save the date!
Mark your calendar! The Adelaide Intermediary Program's annual and much-anticipated celebration of the South Australia's achievements in the SA medtech and healthtech sector will get underway 14 November 2024 5.30 pm - 9 pm at the SkyCity Ballroom, North Terrace, Adelaide. Presented by MTPConnect, the Government of South Australia, and sponsored by FB Rice in partnership with AusBiotech, this is an opportunity for all across SA's ecosystem to come together and celebrate with a round of APPLAUSE.

Connect with the Adelaide Intermediary Program's Fee-Free Services
Do you need to elevate your research impact, build connections and access advice to identify funding opportunities? MTPConnect's Adelaide Intermediary Program team will be working from the Tonsley Innovation District on the first Thursday of each month for drop-ins or one-on-one consultations. Access the fee-free services of the program now and book a meeting.

WA Hub’s October Spotlight Features Agili8
Join the WA Life Sciences Innovation Hub for their next WA MTP Sector Spotlight featuring Agili8 founder and CEO Esther Oh as she shares how their XRAI Vision® platform is revolutionizing healthcare for remote and regional communities. On 15 October 2024, 5 pm - 7:30 pm AWST in Nedlands.

Diabetes Australia and ACADI launch the Australian Diabetes Clinical Trials Network
Diabetes Australia and the Australian Centre for Accelerating Diabetes Innovation (ACADI), a TTRA research centre, have joined forces to announce the Australian Diabetes Clinical Trials Network (ADCTN), a research initiative designed to increase the number of diabetes clinical trials in Australia. The groundbreaking new collaboration in diabetes research will improve outcomes for people living with diabetes.

SABRE Alliance Futures Summit 2024
Join the SABRE Futures Summit at the University of Adelaide featuring Australia's Chief Scientist, Dr. Cathy Foley AO, alongside national leaders in science and innovation. Attendees will participate in high-stakes scenario exercises aimed at redefining Australia’s biosecurity and chemical, biological, radiological, and nuclear (CBRN) strategies. The event also presents opportunities for collaboration, exploring the intersection of the National Science and Research Priorities and the Future Made in Australia Act to propel scientific ideas into the global market. On Wednesday 16 October 2024, 8:30 AM - 4:30 PM in Adelaide.

The Australian Clinical Entrepreneur Program (AUSCEP) Closing Soon!
The Australian Clinical Entrepreneur Program (AUSCEP), is an industry-leading innovation program designed to advance clinician-led transformation across Australia's healthcare workforce. Applications are now open for the 2024 Cohort for AHPRA healthcare workers in New South Wales and Victoria. Go to AUSCEP.au to access Course Information, prepare your application and apply by 4 October 2024.

Mark your Calendars for WA Life Sciences & Innovation Hub's Spotlight 2024
Save the date for the ‘Spotlight on 2024’ on 26 November 2024! Brought to you by the WA Life Sciences Innovation Hub, Life Sciences WA and AusBiotech, the event will celebrate Western Australia’s dynamic life sciences sector. You are invited to join the Hub in spotlighting the achievements and good news stories from the WA sector over the year. Interested in sponsoring the event? Reach out to Rebekah Hinton.

New Role: Senior Therapeutic Commercialisation Specialist, TTRA program
MTPConnect is seeking a Senior Therapeutic Commercialisation Specialist to drive the drugs stream for the new Targeted Translation Research Accelerator (TTRA) Drugs and Devices program. Working hand in hand with MTPConnect’s in-house specialists, you will also lead the design, delivery, and coordination of a range of high-value project acceleration activities and events for the funded companies to improve their capability in translation and knowledge of the commercialisation process for therapeutics, enabling them to springboard to the next investment opportunity. Applications close Sunday 6 October 2024. Visit our Careers page to find out more and to apply!

MTPConnect Team News!
We are thrilled to welcome three new team members to MTPConnect as part of the Adelaide Intermediary Program. Dr Nathalie Taquet has been appointed as Business Development Director South Australia and joined us in late September. In October we will welcome Dr Santhni Subramaniam as Industry Development Officer South Australia and Belinda Turner as Engagement and Communications Manager South Australia.

Sector Snapshot

CTCM Round 1 awardee, ARIA Research, has taken out the Robert Pataki Special Accolade for Healthtech Design at the Australian Good Design Awards. The award encourages the next generation of designers and innovators to create conceptual design solutions aimed at helping to improve the quality of life for people living with a disability, who live in an aged care environment and for people working within the Healthcare System
Checkout out CSIRO's new online resource to increase antimicrobial resistance knowledge - 'AMR Action and Insights'. It will provide evidence-based, accessible information to inform policy and action to reduce the impact of antimicrobial resistance (AMR) on human, animal and environmental health. The 'AMR Action and Insights' website is an initiative of CSIRO Minimising Antimicrobial Resistance Mission, which is supported by the Australian Antimicrobial Resistance Network (AAMRNet), established and operated by MTPConnect.
Great to see this story in Stockhead digging into our latest report on Australia's clinical trials sector - one of our country's most important and valuable services exports. See what our CEO Stuart Dignam says about the future growth of the sector and hear from some of Australia's innovative life sciences companies on why they conduct clinical trials locally
Our Australian Antimicrobial Resistance Network (AAMRNet) Co-Chair, Andrew Bowskill, was quoted in a recent AFR article, Why big pharma wants the government to pay it to make drugs
Clinical-stage pharmaceutical company ENA Respiratory has announced extension of U.S. Department of Defense funding for its novel prophylactic antiviral, after being awarded an additional US $3.13 million contract
German 3D printing medical implant pioneer BellaSeno plans to launch a fully automated production facility in Australia by mid-2025 to make its resorbable soft tissue and bone reconstruction implants - with support from Queensland government’s Industry Partnership Program, according to 3DPrint.com
Telix has announced an agreement to acquire RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network distributing PET, SPECT and therapeutic radiopharmaceuticals.
Vaxxas has Initiated the largest Phase I clinical trial to date, assessing a needle-free avian flu vaccine in collaboration with the US Government Biomedical Advanced Research and Development Authority (BARDA), at over four trial centres in Melbourne and Queensland
Sanofi has paid 100 million euros ($110 million) upfront for the global rights to a neuroendocrine tumor treatment that is nearing a filing for approval
Australia's Chief Scientist Dr Cathy Foley has been awarded ‘Government Pioneer in Quantum’ at the 2024 Quantum Leadership Awards, held in Washington D.C
CSL and their partner Arcturus Therapeutics announced the Japan's Ministry of Health, Labor, and Welfare has approved their updated self-amplifying COVID-19 vaccine for protection against the JN.1 lineage of Omicron subvariants.
Dr Jackie Fairley has been appointed to the Board of Baker Heart and Diabetes Institute
Argenica Therapeutics has announced that the independent Data Safety Monitoring Board (DSMB) has recommended that the Phase 2 clinical trial of ARG-007 in acute ischemic stroke patients continues with no modifications to the study protocol
The City of Melbourne has identified biotech as one of five key tech sectors that will shape the city's future.
Find out how Australia is ready to play a leading role in the rise of the global radiopharmaceutical industry with MTPConnect's discussion paper, 'From Mines to Medicines. Australia’s Radiopharmaceuticals Future', outlining a national roadmap to maximise this opportunity
Read MTPConnect's latest snapshot report on Australia’s Clinical Trials Sector released in June 2024
The results are in - read MTPConnect's TTRA impact report out now, ‘Transforming health outcomes for diabetes and cardiovascular disease in Australia – Interim report on impacts of the first Targeted Translation Research Accelerator’
Read the latest report from MTPConnect and its Australian Antimicrobial Resistance Network (AAMRNet): Fighting superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections developed by Evohealth
Read the National Action Plan to Build Australia’s Diagnostic Technology Sector
Check out the 'Discovery to Device' facility for accelerating MedTech commercialisation, in partnership with RMIT and the Victorian Government. Contact Professor Sharath Sriram to find out more
If you would like to hear more from the National Measurement Institute, make sure you sign up for their newsletter
The Victorian Government has produced the Victorian Medtech Capability Directory.
gemaker's website is a great resource for the innovation and commercialisation sector. And s ubscribe to gemaker's Monthly Insights newsletter for researchers, inventors and innovative businesses
Join the mailing list of the new Victorian Medtech Skills and Device Hub, bringing together local businesses, universities and education providers to accelerate Victoria's medtech sector and deliver the workforce of the future

Sector Opportunities

EOI's are now open to attend the ARCS Signature Program, uniquely tailored for senior managers in the medtech and pharmaceutical sector with an ambition to progress into executive leadership roles
Health and Medtech to the Middle East - Investment NSW: Eligible businesses can apply for support to export Health and MedTech products and services to the Middle East – apply for the NSW Going Global Export Program. Selected businesses will receive free support to expand to the Middle East, including targeted business-introductions and networking opportunities at Arab Health 2025. Apply before 6 October 2024
EIO's are now open for the HCF Research Foundation Translational Research Grants 2024 program. The HCF Research Foundation Translational Research Grants (TRG) scheme is focused on the translation of research findings into practice by health service delivery stakeholders. Closes 8 October 2024 AEST
Learn from Department of Industry, Science and Resources representatives about the R&D Tax Incentive Advance Findings for activity eligibility and how to make sure you comply with record keeping requirements. This webinar is designed for small to medium businesses and assumes a basic understanding of the R&D Tax Incentive program. On 15 October 2024. Register!
Therapeutic Innovation Australia, in partnership with Phenomics Australia and ANSTO’s National Deuteration Facility (NDF) is providing access vouchers to TIA and Phenomics Australia facilities as well as NDF via their Pipeline Accelerator scheme. Apply before 31 October 2024
CT:IQ, in collaboration with the Australian Research Data Commons (ARDC), are conducting focus groups with researchers, study coordinators, site staff, and study sponsors. Your insights will inform the Clinical Research Data Sharing Frameworks project, aimed at developing practical resources to support high-quality, efficient, sharing of Australian clinical research data. Four x 60-minute focus group times available, starting 10 October
The Industry Capability Network - Victoria is launching an update to the Victorian Medtech Manufacturing Capability Directory to provide greater coverage of the medtech supply chain in our state. The next issue will be launched on 3 October at ICN-Vic's upcoming Medtech Showcase
Seeking investment for your breakthrough innovation? Apply to become an investee at AusBioInvest 2024
Are you working on groundbreaking diagnostics or medical device countermeasures that address public health? I-CREATE is part of a global network of accelerator hubs that provide product development funding, accelerator services, and access to expertise for innovators developing health security solutions. Start-ups and university-backed projects worldwide can apply for non-dilutive funding ranging from $50K to $200K. This funding supports the development, evaluation, or validation of innovative solutions aligned with BARDA’s mission to enhance pandemic preparedness and health security. Apply for the next cohort in 2025
Nominations are open for BioMelbourne Network's 2025 Women in Leadership Awards. Submit by 20 November 2024
IDE Group's Building Better Futures for Health 2024 applications are now open - check their website
The Industry Growth Program provides support for innovative SMEs to commercialise and grow their business within the National Reconstruction Fund priority areas, such as medical science. Get connected to an Industry Growth Program adviser who will provide tailored advice to support your commercialisation and/or growth project. And you may be eligible to apply for further funding. Apply now
Do you have an innovation that you want to put on SA Health’s radar? Submit your ideas to the SA Health Industry Ideas portal
FundWA Open Door initiative provides local founders with the opportunity to discuss fundraising, or pitch to a member of our team. No warm introduction needed, just apply
Cicada HealthTech Hub Ask an Expert is an exciting opportunity for clinicians, researchers, and health tech founders to gain insights and personalised advice from a distinguished panel of Mentors, Investors, and Funders. Visit the website to book an appointment for a 20-minute session online or at Westmead Innovation Centre
The NSW government and Cicada Innovations are providing nationwide access to free online commercialisation training, 'NSW Deep Tech Commercialisation Program: Foundations
Invest NSW's MVP (Minimum Viable Product) Ventures 2024-2025 supports start-ups and innovative SMEs in the product lifecycle between early-stage research and mature investment opportunities, through grants to drive the commercialisation of highly innovative and new products. Closes 28 February 2025
Perth BioDesign is a part-time 7-month course bringing together multidisciplinary teams to identify unmet clinical needs and work towards inventing a medical technology or digital health solution, whilst learning about the development process. Apply!
The WA Commercialisation Bridge Grant, specifically targets innovation-driven small enterprises and startups in WA, to assist them in becoming sustainable, scalable businesses.
Applications are open for X-TEND WA, a competitive co-investment grants program, investing in organisations that deliver initiatives to assist and support the WA Innovation Ecosystem provided by WA's Department of Jobs, Tourism, Science and Innovation
Co-Funding Partnerships Program (Co-FPP) is an ongoing Program of the Future Health Research and Innovation (FHRI) Fund to establish collaborations and funding partnerships to bring new non-government funding for health and medical research and innovation to WA, and to build a culture that supports co-operation and interconnectedness. Applications are open until 17 October 2024
Carb-X has announced a new funding round to fill major R&D gaps in the global pipeline for bacterial infections, with four distinct product themes. Submit expressions of interest by 4 October 2024
WA's Health and medical life sciences industry: Market Access Grant Scheme 2024 supports Western Australian health and medical life sciences companies in advancing their business development through national and international conferences and events in 2024. Funding support is 80% of eligible costs (excluding GST) and up to a maximum of $5,000 per company. Closes when all funds are expended
CSIRO Kick-Start is a year-round initiative providing matched funding support for innovative Australian start-ups and small businesses, with access to CSIRO’s research expertise and capabilities to help grow and develop their business
The Seed-Start program (South Australia) supports commercialisation of innovative, early-stage SA startups. Applications are ongoing
Curtin University has launched Curtin Invest Angel Syndicate to support startups and innovation-driven businesses emerging from its Curtin Accelerate program. Find out more on how to join the syndicate
Check out the APR.Intern internships available in the medtech and pharma sector!
Are you a biotech innovator looking for specialised facilities? Jumar Bioincubator, Australia's newest biotech incubator is offering affordable lab and office space, along with practical support, to nurture young biotech ventures. Find out more
ATSE's IMNIS Ignite is a postgraduate internship program connecting industry-ready IMNIS Engage alumni with industry-based internships at host organisations. Register your interest.
Keep up with funding opportunities and subscribe to the monthly MRFF newsletter, from the Australian Government Department of Health and Aged Care
Do you have a great idea for a medical or assistive device and need R&D assistance? Connect with MDPP

Events

3 October 2024 - Medtech Showcase 2024, Industry Capability Network (Melbourne)
8-10 October 2024 - BioProcessing Network 2024 Conference (Brisbane)
9 October 2024 - BioSymposium - Innovating Antibody-Drug Conjugates: From Mechanisms to Market, BioMelbourne Network (CSIRO, Clayton)
9-17 October 2024 - MTPConnect Australian Medtech Delegation to US and Canada
15 October 2024 - WA MTP Sector Spotlight featuring Agili8 (Perth)
15 October 2024 - Guide to eligibility certainty and record keeping in the R&DTI, DISR (Online)
15-17 October 2024 - The Medtech Conference, AdvaMed (Toronto, Canada)
16 October 2024 - SABRE Alliance Futures Summit 2024, SABRE Alliance (Adelaide)
16-17 October 2024 - Jumar BioElevate (Melbourne)
17 October 2024 - The Healthtech Muster, Tenmile (Sydney)
17 - 23 October 2024 - ANDHealth HLTH US Delegation 2024
20-23 October 2024 - HLTH (Las Vegas, US)
17 October 2024 - Cyber security for everyone, Cooperative Research Australia (online)
22 October 2024 - RegConnect24, MTAA (Sydney)
23-24 October 2024 - MTAA MedTech Conference, MTAA (Sydney)
28 October 2024 - Biodesign APAC Showcase: Game Changers in Medtech Innovation (Melbourne)
28 - 30 October 2024 - SWITCH - Singapore Week of Innovation & Technology (Singapore)
29 October 2024 - AusBioInvest 2024 (Melbourne)
30 October - 1 November 2024 - AusBiotech 2024 National Conference (Melbourne)
31 October 2024 - MIME Symposium 2024, Monash (Melbourne)
7 November 2024 - Promoting success: telling your story with impact, Cooperative Research Australia (online)
14 November 2024 - APPLAUSE24 - save the date, Adelaide Intermediary Program (Adelaide)
19 November 2024 - Women in MedTech Networking Event - Mentoring Program, MTAA (Sydney)
19 November 2024 - National Biotech and Medtech Development and Commercialisation Summit, AusBiotech & MTPConnect (Canberra)
21 November 2024 - 2024 BioMelbourne Network Annual General Meeting & Networking Event (Melbourne)
26 November 2024 - Spotlight on 2024 - Save the date, WA Life Sciences & Innovation Hub (Perth)
26 November 2024 - BioForum – Biotech scandal to SaaS Success: Fireside chat with Theranos ’survivor’ Marissa Senzaki, MDMD (Melbourne)
27 November 2024 - Scaling healthtech with sustainable strategies, MDMD (Melbourne)
28 November 2024 - Practical co-design for everyone: the secret to success, Cooperative Research Australia (online)
2-6 December - Global Tech and Innovation Program 2024 (WA)
11 December 2024 - BioMelbourne Network, AusBiotech and ARCS VIC End-of-Year Function 2024 – save the date (Melbourne)
25 - 27 February 2025 - Global Life Science Partnering & Investor Conference, BioCom California (La Jolla, California US)
18 - 19 March 2025 - Life Sciences Summit, Biotech NZ & NZTech (Wellington, New Zealand)
16 May 2025 - Connecting Women Lunch, BioMelbourne Network (Melbourne)

To see what industry events are coming up in 2024, visit our events page.

Case Study Showcase | Internship Program Builds Clinical Trial Workforce and Supports Regions

More than 90,000 Australians participated in clinical trials in 2022. That same year, the nation spent $1.6 billion on clinical trials, around 1,850 trials commenced and the sector employed 8,000 skilled workers. Multiple reports, including MTPConnect’s Australian Clinical Trials Sector reports and REDI Skills Gap Analysis reports have identified workforce shortages in this sector. The rapid growth of the medical technology, biotechnology and pharmaceuticals sector is causing serious shortages of skilled workers, especially in clinical trial operations and pharmaceutical manufacturing. The VCCC Alliance SKILLED Internship program is building a future workforce to support the growth of clinical trials in cancer and non-cancer research through support from the REDI initiative. Find out more...

Sector Profile: Viral Vector Manufacturing Facility (VVMF)

Viral Vector Manufacturing Facility (VVMF) has a vision to be a leading commercial viral vector contract development and manufacturing organisation (CDMO), partnering to deliver advanced therapeutic solutions to patients globally and services regionally. Learn more in our Sector Directory.